1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsImpact of Malaria Vector Diversity on Intervention Strategies is sponsored by Fogarty International Center at NIH. Examines differences in mosquito populations' responses to malaria interventions to improve understanding of malaria parasite transmission persistence.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Not following) "Currently not following the site, click to follow") A **. gov** website belongs to an official government organization in the United States.
Advancing Science for Global Health * About Us (current section) * Our Role in Global Health * International Relations * International Services, Passports and Visas * NIH Global Health Funding * Search Current and Recent Grants * Human Subjects Policies * Administrative Supplements * NIH Grants and Grantees * Foreign NIH Grant Applicants * Global Health Resources * Global Health Research Topics * Center for Global Health Studies * NIH Resources in Asian Languages * NIH Resources in Spanish * NIH Support of International Research * Nongovernmental Organizations (NGOs) * Chronic, Noncommunicable Diseases Research Training * Ecology and Evolution of Infectious Diseases * Global Health Fellows & Scholars/LAUNCH * Global Infectious Disease Research Training * HIV-associated Noncommunicable Diseases Research * International Bioethics Training * International Research Scientists * Global Health Research News * Global Health Matters Newsletter * Events, Conferences and Workshops * Fogarty Trainee Profiles * Early-career Researcher Profiles Advancing Science for Global Health * Our Programs Benefit the U.S. and the World * Our Impact: Fact Sheets * Our Impact on U.S. States * Global Scientific Advances Benefit the U.S. Public * Our Role in Global Health * International Services, Passports & Visas **NIH Websites Are Changing** # DIEPS Publications & News Archive Find more information on the Division of International Epidemiology and Population Studies (DIEPS) * Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty’s Samantha Bents, Nídia Trovão, and Cécile Viboud _Scientific Reports_, June 24, 2024 * Impacts of human mobility on the citywide transmission dynamics of 18 respiratory viruses in pre- and post-COVID-19 pandemic years[](https://www. fic. nih.
gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), co-authored by Fogarty’s Amanda C. Perofsky, Chelsea L.
Hansen, and Cécile Viboud _Nature Communications_, May 16, 2024 * Charting the evolutionary course of influenza: Insights into epidemic dynamics _Global Health Matters_, March/April 2024 * The risk of mpox importation and subsequent outbreak potential in Chinese mainland: a retrospective statistical modelling study[](https://www. fic. nih.
gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), co-authored by Fogarty’s Kaiyuan Sun _Infectious Diseases of Poverty_, February 29, 2024 * Synchrony of Bird Migration with Global Dispersal of Avian Influenza Reveals Exposed Bird Orders[](https://www. fic.
nih. gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), co-authored by Fogarty’s Nidia Trovão _Nature Communications_, February 6, 2024 * Comparative evolution of influenza A virus H1 and H3 head and stalk domains across host species, co-authored by Fogarty’s Nidia Trovão and Joshua Cherry * Effects of Cooking with Liquefied Petroleum Gas or Biomass on Stunting in Infants[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), authored by HAPIN Trial investigators, supported by Fogarty and other NIH Institutes and Centers New _England Journal of Medicine_, January 4, 2024 * Liquefied Petroleum Gas or Biomass Cooking and Severe Infant Pneumonia[](https://www. fic. nih.
gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), authored by HAPIN Trial investigators, supported by Fogarty and other NIH Institutes and Centers _New England Journal of Medicine_, January 4, 2024 * Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertainty[](https://www. fic.
nih. gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), co-authored by Fogarty’s Cécile Viboud _Nature Communications_, November 20, 2023 * A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty’s Nídia Trovão _European Journal of Human Genetics_, November 8, 2023 * Evolutionary and spatiotemporal analyses reveal multiple introductions and cryptic transmission of SARS-CoV-2 VOC/VOI in Malta, co-authored by Fogarty's Nídia S.
Trovão _Microbiology Spectrum_, October 6, 2023 * Accelerating Bayesian inference of dependency between mixed-type biological traits, co-authored by Fogarty’s Nídia S. Trovão and Josh Cherry _PLOS Computational Biology_, August 28, 2023 * Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts[](https://www. fic.
nih. gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), co-authored by Fogarty’s Nídia S.
Trovão _Science Translational Medicine_, August 9, 2023 * Sequential viral introductions and spread of BA. 1 across Pakistan provinces during the Omicron wave[](https://www. fic.
nih. gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), co-authored by Fogarty’s Nídia S.
Trovão, David Spiro, and Zeba Rasmussen _BMC Genomics_, August 3, 2023 * Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica[](https://www. fic. nih.
gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty’s Kaiyuan Sun _Communications Medicine_, July 22, 2023 * Evaluation: Division of International Epidemiology and Population Studies, conducted November 2022, posted online June 2023 * T Residues Preceded by Runs of G Are Hotspots of T→G Mutation in Bacteria, authored by Fogarty's Joshua Cherry _Genome Biology and Evolution_, June 1, 2023 * Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2, co-authored by Fogarty's Cécile Viboud _Proceedings of the National Academy of Sciences of the United States of America_, May 30, 2023 * Application of Phylodynamic Tools to Inform the Public Health Response to COVID-19: Qualitative Analysis of Expert Opinions, co-authored by Fogarty's Nídia Trovão _JMIR Formative Research_, April 21, 2023 * Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022, co-authored by Fogarty's Cécile Viboud _elife_, February 22, 2023 * A Retrospective Modeling Study of the Targeted Non-Pharmaceutical Interventions During the Xinfadi Outbreak in the Early Stage of the COVID-19 Pandemic - Beijing, China, 2020 , co-authored by Fogarty's Kaiyuan Sun _China CDC Weekly,_ February 3, 2023 * Restriction Endonuclease-Based Modification-Dependent Enrichment (REMoDE) of DNA for Metagenomic Sequencing, co- authored by Fogarty's Joshua Cherry _Applied and Environmental Microbiology_, January 31, 2023 * Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa, co-authored by Fogarty’s Kaiyuan Sun & Cécile Viboud _Nature Communications_, January 16, 2023 * Global dissemination of influenza A virus is driven by wild bird migration through arctic and subarctic zones, co-authored by Fogarty's Nídia Trovão _Molecular Ecology_, January 2023 * Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.
2 in Shanghai, February-June 2022, co-authored by Fogarty’s Kaiyuan Sun _Emerging Microbes & Infections_, November 21, 2022 * Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants, co-authored by Fogarty’s Kaiyuan Sun & Cécile Viboud _BMC Medicine_, November 15, 2022 * Global dissemination of influenza A virus is driven by wild bird migration through arctic and subarctic zones, co-authored by Fogarty's Nídia S Trovão _Molecular Ecology_, October 14, 2022 * Liquefied Petroleum Gas or Biomass for Cooking and Effects on Birth Weight[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer") authored by HAPIN Trial investigators, supported by Fogarty and other NIH Institutes and Centers _New England Journal of Medicine_, October 10, 2022 * COVID-19 Exposure Assessment Tool (CEAT): Exposure quantification based on ventilation, infection prevalence, group characteristics, and behavior, co-authored by Fogarty's Nídia S Trovão _Science Advances_, September 30, 2022 * Origins and Evolution of Seasonal Human Coronavirusesco-authored by Fogarty’s James Otieno, Joshua Cherry, David Spiro, and, Nídia Trovão * A systematic review of household energy transition in low and middle income countries[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty's Joshua Rosenthal _Energy Research and Social Science_, April 2022 * Evolutionary history and introduction of SARS-CoV-2 Alpha VOC/B. 1. 1.
7 in Pakistan through international travelers, co-authored by Fogarty's Nídia Trovão, Zeba Rasmussen, and David Spiro _Virus Evolution_, March 17, 2022 * Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018[](https://www. fic. nih.
gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), co-authored by Fogarty's Chelsea Hansen and Dr. Cecile Viboud _JAMA Network Open_, February 28, 2022 * Assessing the Effects of Cooking Fuels on Anopheles Mosquito Behavior: An Experimental Study in Rural Rwanda[](https://www. fic.
nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty's Joshua Rosenthal _The American Journal of Tropical Medicine and Hygiene_, February 21, 2022 * Determinants of vaccine coverage and timeliness in a northern Pakistani village, co-authored by Fogarty's Chelsea Hansen and Zeba Rasmussen _PLOS One_, February 17, 2022 * Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa, featuring Fogarty's David J Spiro and Nídia S Trovão as co-authors _iScience_, February 5, 2022 * SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal, co-authored by Fogarty's Dr. Nídia Trovão _Communications Medicine_, January 28, 2022 * The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 – September 2021, co-authored by Fogarty's Amanda Perofsky and Dr. Cecile Viboud _Clinical Infectious Diseases_, January 27, 2022 * Association between personal exposure to household air pollution and gestational blood pressure among women using solid cooking fuels in rural Tamil Nadu, India[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), authored by HAPIN trial investigators _Environmental Research_, January 2022 * LPG stove and fuel intervention among pregnant women reduce fine particle air pollution exposures in three countries: Pilot results from the HAPIN trial _Environmental Pollution_, December 15, 2021 * SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021, co-authored by Fogarty's Dr. Kaiyuan Sun and Dr. Cecile Viboud _medRxiv,_ December 4, 2021 * Fidelity an adherence to a liquefied petroleum gas stove and fuel intervention during gestation: the multi-country Household Air Pollution Intervention Network (HAPIN) randomized controlled trial, co-authored by Fogarty's Joshua Rosenthal _International Journal of Environmental Research and Public Health,_ November 29, 2021 * Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing, co-authored by Fogarty's Dr. Cecile Viboud _PLoS Comput Biol.
,_ October 28, 2021 * Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines, co-authored by Fogarty's Dr. Cecile Viboud _PLoS Medicine_, October 18, 2021 * Genetic lineage characterization and spatiotemporal dynamics of classical insect-specific flaviviruses: outcomes and limitations, co-authored by Fogarty's Nidia Trovao _Virus Research_, October 2, 2021 * Examining the relationships between early childhood experiences and adolescent and young adult health status in a resource-limited population: A cohort study[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty's Zeba Rasmussen and Chelsea Hansen _PLoS Medicine_, September 28, 2021 * Social groups constrain the spatiotemporal dynamics of wild sifaka gut microbiomes[](https://www. fic. nih.
gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty's Amanda Perofsky _Molecular Ecology_, September 24, 2021 * Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination, co-authored by Fogarty's Dr. Cecile Viboud _\_medRxiv\__, September 2, 2021 * A comprehensive look at the COVID-19 pandemic death toll, co-authored by Dr. Cecile Viboud, * Tracing the Source of Influenza A Virus Zoonoses in Interconnected Circuits of Swine Exhibitions[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), featuring Fogarty's Amanda Perofsky as co-lead author _The Journal of Infectious Diseases_, August 1, 2021 * Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan, co-authored by Fogarty's Nidia Trovao _Infection Genetics and Evolution_,July 14, 2021 * Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level, co-authored by Fogarty's Nidia Trovao _Emerging Infectious Diseases_, June 27, 2021 * Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making, co-authored by Fogarty's Dr. Cecile Viboud _PLoS Biology_, June 17, 2021 * Toward the use of neural networks for influenza prediction at multiple spatial resolutions, co-authored by Fogarty's Dr. Cecile Viboud _Science Advances_, June 16, 2021 * Hospital utilization rates for influenza and RSV: a novel approach and critical assessment, co-authored by Fogarty's Dr. Cecile Viboud _Population Health Metrics_, June 14, 2021 * RSV genomic diversity and the development of a globally effective RSV intervention, co-authored by Fogarty's Dr. Cecile Viboud and Dr.David Spiro * Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021, co-authored by Fogarty's Dr. Cecile Viboud * The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China, co-authored by Fogarty's Dr. Cecile Viboud _Science Advances_, May 7, 2021 * Modeling networks: How Fogarty made epidemiology history during the COVID-19 pandemic May / June 2021 _Global Health Matters_ * Model-based evaluation of alternative reactive class closure strategies against COVID-19, co-authored by Fogarty's Dr. Cecile Viboud _medRxiv_, April 23, 2021 * A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty's Joshua Rosenthal _BMC Medical Research Methodology_, April 12, 2021 * Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States, co-authored by Fogarty's Dr. Kaiyuan Sun and Dr. Cecile Viboud _medRxiv_, March 26, 2021 * Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area, co-authored by Fogarty's Nidia Trovao _JCI Insight_, March 22, 2021 * Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China, co-authored by Fogarty's Dr. Kaiyuan Sun and Dr. Cecile Viboud _Nature Communications_, March 9, 2021 * Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis, co-authored by Fogarty's Dr. Cecile Viboud _Lancet Glob Health_, March 8, 2021 * Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty's Dr. Cecile Viboud _Nature,_ October 25, 2021 * Substantial and sustained reduction in under-5 mortality, diarrhea, and pneumonia in Oshikhandass, Pakistan: evidence from two longitudinal cohort studies 15 years apart[](https://www. fic. nih.
gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), co-authored by Fogarty scientists _BMC Public Health_, May 24, 2020 * Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2[](https://www. fic.
nih. gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), featuring Fogarty's Dr. Kaiyuan Sun as lead author, and Fogarty's Dr. Cecile Viboud as co-senior author _Science_, November 24, 2020 * Preparing for the future implementation of respiratory syncytial virus vaccines30478-3/fulltext)[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Dr. David Spiro _The Lancet Respiratory Medicine_, Jan 21, 2020 * [Molecular characterization of respiratory syncytial viruses circulating in a paediatric cohort in Amman, Jordan [Open access]](https://www. microbiologyresearch. org/content/journal/mgen/10.
1099/mgen. 0. 000292#html_fulltext)[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty scientists _Microbial Genomics_, Sep 18, 2019 * [Population-level mathematical modeling of antimicrobial resistance: a systematic review [Open access]](https://bmcmedicine. biomedcentral. com/articles/10.
1186/s12916-019-1314-9)[](https://www. fic. nih.
gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty scientists _BMC Medicine_, Apr 24, 2019 * Disease modelers mark Fogarty’s 50th anniversary Nov / Dec 2018 _Global Health Matters_ * Fogarty International Center collaborative networks in infectious disease modeling: Lessons learnt in research and capacity building _Epidemics_ via PubMed, Oct 23, 2018 (online) * Emergence and evolution of novel reassortant influenza A viruses in canines in southern China * How historical disease detectives are solving mysteries of the 1918 flu[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer") _The Conversation_, Mar 5, 2018 * A review of the 1918 herald pandemic wave: importance for contemporary pandemic response strategies30726-3/fulltext)[](https://www. fic. nih.
gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer") _Annals of Epidemiology_, Feb 27, 2018 * Infection forecasts powered by big data[](https://www. fic.
nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), featuring Fogarty scientist Dr. Cecile Viboud _Nature Outlook_, Mar 7, 2018 * Fogarty provides training to build expertise in managing disease outbreaks Jan / Feb 2018 _Global Health Matters_ * Co-founder of Fogarty's RAPIDD modeling program Dr Ellis McKenzie is remembered May / Jun 2017 _Global Health Matters_ * Report:[Division of Epidemiology and Population Studies Evaluation [PDF <1 MB, 34 pages]](https://www.
fic. nih. gov/About/Staff/Policy-Planning-Evaluation/Documents/DIEPSReview2016.
pdf) (2016) * NIH-led effort examines use of big data for infectious disease surveillance Fogarty/NIH news, Nov 14, 2016 * Big Data for Infectious Disease Surveillance and Modeling[](https://www. fic. nih.
gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer") Supplement to the _Journal of Infectious Diseases_, Dec 1, 2016 * Your flu risk may be linked to the year you were born[](https://www. fic.
nih. gov/Pages/ExitDisclaimer. aspx "FIC exit disclaimer"), with Fogarty's Dr Cecile Viboud * First flu is forever[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer"), co-authored by Fogarty's Dr Cecile Viboud _Science_, November 11, 2016 * Timing and periodicity of influenza epidemics[](https://www. fic. nih.
gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer") co-authored by Fogarty's Dr. Cecile Viboud _PNAS_, Nov 3, 2016 (online) * Fogarty trains Pakistani scientists in biorisk management Jul / Aug 2016 _Global Health Matters_ * Fogarty's RAPIDD program has catalyzed the field of infectious disease modeling May / Jun 2016 _Global Health Matters_ * Ebola, Zika modelers aim to inform policy decisions Mar / Apr 2016 _Global Health Matters_ * Global Mortality Impact of the 1957–1959 Influenza Pandemic[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer") _The Journal of Infectious Diseases_, March 1, 2016 * What dose of medication is best to prevent the evolution of drug resistance? [](https://www. fic.
nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer") Penn State news, January 28, 2016 * Global swine trade facilitates evolution, spread of flu Mar / Apr 2015 _Global Health Matters_ * Study probes link between intestinal infections, child development Nov / Dec 2014 _Global Health Matters_ * Fogarty study sheds light on role of climate in influenza transmission * Solving a math puzzle to stop infectious disease Sep / Oct 2011 _Global Health Matters_ * Fogarty supported scientists work to slow the spread of drug-resistant disease organisms[](https://www.
fic. nih. gov/Pages/ExitDisclaimer.
aspx "FIC exit disclaimer") _Penn State Science News_, June 22, 2011 * RAPIDD program veteran tracks viruses transmitted by bats May / Jun 2011 _Global Health Matters_ * Mexican flu study by Fogarty supports social distancing May / Jun 2011 _Global Health Matters_ * Report: [Division of International Epidemiology and Population Studies Review 2009 [PDF <1K, 52 pages]](https://www. fic. nih.
gov/About/Staff/Policy-Planning-Evaluation/Documents/DIEPSReview2009. pdf) * National Institutes of Health * U.S. Department of Health & Human Services Fogarty International Center at the National Institutes of Health 31 Center Drive, MSC 2220, Bethesda, MD 20892-2220 USA NIH... Turning Discovery Into Health®
According to the current listing, eligibility includes: University of Maryland Baltimore; The Malaria Alert Center. Confirm the full requirements in the official notice before applying.
Impact of Malaria Vector Diversity on Intervention Strategies is funded by Fogarty International Center at NIH. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Maryland. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Digital Health Impact Accelerator (DHIA) is sponsored by The Global Fund to Fight AIDS, Tuberculosis and Malaria and The Rockefeller Foundation (in collaboration with other partners). The Digital Health Impact Accelerator (DHIA) is accelerating countries' digital health transformation in sub-Saharan Africa. It focuses on scaling power, internet connectivity, and digital data system interoperability solutions for integrated, patient-centered care.
Malaria Research and Eradication Strategies is sponsored by Global Diseases Research Awards. This award focuses on novel therapies, vaccines, vector control strategies, or insights into malaria transmission that could drive global eradication efforts. Submissions should include detailed research on malaria pathogenesis, treatment, vaccines, or innovative vector control methods, along with evidence of effectiveness in the field. Entries are evaluated on their potential to reduce malaria transmission, improve treatment outcomes, and make a substantial impact on global eradication efforts.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article